Is Taiwan Bio Therapeutics stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Taiwan Bio Therapeutics 10 years ago, but if you had invested on Friday 13th of May 2022 when the price was TWD36.42, you would have made a profit of TWD4.93 per share or 13.54%
Yes, the average daily trading liquidity for Taiwan Bio Therapeutics is TWD153 866 thousand. You should therefore be able to get in and out of your positions relatively fast.
Taiwan Bio Therapeutics has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Taiwan Bio Therapeutics to be medium [0.7 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.